Hybrid VMAT-3DCRT as breast cancer treatment improvement tool.

Sci Rep · 2024 · PMC10764879 · PMID 38172237

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

extremely significantno p-value reported

For LungCL and LungILCL, there is also an extremely significant difference highlighting the quality of the 3DCRT dosimetry.

also in 7,787 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.